Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

3Total

Not Applicable (1)

P 2 (1)

P 4 (1)

Trial Status

Completed2

Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials

NCT05586477Phase 4Completed

Diphenhydramine and Sweating

NCT05861219Not ApplicableUnknownPrimary

Alternative Haemodiafiltration in Summer Season for Chronic Kidney Disease Patients

NCT00335478Phase 2Completed

Daptomycin in Treating Neutropenia and Fever in Patients With Cancer

Showing all 3 trials

Sweating